Product/Composition:- | Torsemide tablets |
---|---|
Strength:- | 10 mg, 20 mg, 100 mg |
Form:- | Tablet |
Reference Brands:- | Demadex(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Torsemide is a loop diuretic that inhibits the sodium-potassium-chloride co-transporter in the kidneys, increasing urine production. It effectively reduces fluid buildup, edema, and blood pressure. Benefits include rapid symptom relief, improved heart and kidney function, enhanced fluid control, and better management of heart failure and hypertension.
Torsemide tablets, marketed as Demadex, are approved in the US by the FDA and in the EU via EMA for edema and hypertension management. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier submission, regulatory pathways, and market access strategies, visit PharmaTradz. Proper regional compliance supports timely approval, safe use, and global availability of torsemide tablets, enabling effective treatment of fluid retention and cardiovascular conditions worldwide.